NCT03098589 2025-03-30Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)CelgeneCompleted1,149 enrolled
NCT00020189 2013-06-19Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck CancerNational Cancer Institute (NCI)Phase 2 Completed